Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per mL

Ülke: Yeni Zelanda

Dil: İngilizce

Kaynak: Medsafe (Medicines Safety Authority)

Aktif bileşen:

Glycopyrronium bromide 0.5 mg/mL; Neostigmine metilsulfate 2.5 mg/mL

Mevcut itibaren:

Boucher & Muir (NZ) Ltd t/a Mercury Pharma (NZ)

INN (International Adı):

Glycopyrronium bromide 0.5 mg/mL

Farmasötik formu:

Solution for injection

Kompozisyon:

Active: Glycopyrronium bromide 0.5 mg/mL Neostigmine metilsulfate 2.5 mg/mL Excipient: Citric acid Citric acid monohydrate Dibasic sodium phosphate dodecahydrate Sodium hydroxide Water for injection

Reçete türü:

Prescription

Tarafından üretildi:

PCAS Finland Oy

Terapötik endikasyonlar:

Reversal of residual non-depolarising (competitive) neuromuscular block.

Ürün özeti:

Package - Contents - Shelf Life: Ampoule, glass, Type I - 10 dose units - 24 months from date of manufacture stored at or below 25°C protect from light

Yetkilendirme tarihi:

2012-08-30